Table 1.

List of different clinical isolates of KA and PKDL used for present study

Study codea	Reference Codeb	Agec	Sexd	Countrye/Datef
T2	MHOM/IN/10/IICB-AKS	2 years 3 months	Male	INDIA/2010
T3	MHOM/IN/10/IICB-MS	11 years	Male	INDIA/2010
T4	MHOM/IN/10/IICB-LH	56 years	Male	INDIA/2010
T5	MHOM/IN/10/IICB-LB	12 years	Male	INDIA/2010
T7	MHOM/IN/10/IICB-SIB	17 years	Female	INDIA/2010
P1g	MHOM/IN/08/PG-MA	35 years	Male	INDIA/2008
PG2	MHOM/BD/06/MJ	39 years	Male	BANGLADESH/2006
PG3	MHOM/BD/07/MM	17 years	Male	BANGLADESH/2007
PG4	MHOM/BD/07/SA	8 years	Male	BANGLADESH/2007
DD8h	MHOM/IN/80/DD8	WHO reference strain for Leishmania donovani
K27h	MHOM/SU/74/K27	WHO reference strain for L. tropica

^aStudy codes given to the collected clinical isolates of KA and PKDL for the present study

^bReference codes were given to the isolates according to the WHO nomenclature rules followed for Leishmania sp. [Evans DA (1989) World Health Organization, Geneva, pp 15–40]

^cAge of the patients of KA or PKDL

^dSex of the patients of KA or PKDL

^eCountry of the patients

^fYear of collection of the isolates from patients

^gPKDL isolate

^hDD8 and K27, two WHO reference strains for Leishmania donovani and L. tropica